Transgenic models to assess the neuropathogenic potential of HIV-1 proteins and cytokines

Curr Top Microbiol Immunol. 1995;202:187-205. doi: 10.1007/978-3-642-79657-9_13.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • AIDS Dementia Complex* / pathology
  • Animals
  • Animals, Genetically Modified*
  • Brain / pathology
  • Cytokines / genetics
  • Cytokines / physiology*
  • Disease Models, Animal*
  • Gene Expression Regulation, Developmental
  • Genes
  • Genes, Viral
  • Glial Fibrillary Acidic Protein / genetics
  • Granulocyte-Macrophage Colony-Stimulating Factor / genetics
  • Granulocyte-Macrophage Colony-Stimulating Factor / physiology
  • HIV Envelope Protein gp120 / genetics
  • HIV Envelope Protein gp120 / physiology
  • HIV-1 / genetics
  • HIV-1 / pathogenicity*
  • Humans
  • Interleukin-6 / genetics
  • Interleukin-6 / physiology
  • Mice
  • Mice, Transgenic
  • Promoter Regions, Genetic
  • Rats
  • Recombinant Fusion Proteins / biosynthesis
  • Retroviridae Proteins / genetics
  • Retroviridae Proteins / physiology*
  • Species Specificity
  • Transgenes
  • Viral Structural Proteins / genetics

Substances

  • Cytokines
  • Glial Fibrillary Acidic Protein
  • HIV Envelope Protein gp120
  • Interleukin-6
  • Recombinant Fusion Proteins
  • Retroviridae Proteins
  • Viral Structural Proteins
  • Granulocyte-Macrophage Colony-Stimulating Factor